Defy Gravity, Kill Cancer

At midnight tonight, it’s over. March 21, 2024 [WEBSITE]( | [UNSUBSCRIBE]( WARNING: This AI opportunity will be pulled from the internet at MIDNIGHT tonight Defy Gravity, Kill Cancer CHRIS CAMPBELL Dear Reader, On Earth, cancer is a slow and insidious killer, taking years to develop and spread. But, as scientists at the International Space Station discovered recently, cancer becomes a beast unleashed when taken in space. Thing is… In the weightlessness of space, cancer cells grow at a mind-blowing rate, tripling in size in just 10 days. (On earth, this rate of growth takes TEN YEARS.) The culprit behind this accelerated growth? Microgravity, the weak gravitational force that astronauts experience in space. In this environment, cancer cells are no longer restrained by the normal boundaries of tissue. They invade and metastasize, spreading to other areas of the body with terrifying speed. Sure, this might sound like a nightmare, but… This rapid growth has given the space station scientists an opportunity to study cancer on fast-forward. Blessing in Disguise The rapid development of cancer in space means that scientists can test potential treatments at an equally accelerated pace. And they may have already found a promising lead: a gene called ADAR1. ADAR1 has been on the radar of cancer researchers for about a decade, linked to the ability of cancer cells to clone themselves and evade the immune system. This gene is activated when cells are under stress and has been implicated in about 20 different types of cancer, particularly when cancers become resistant to therapy. By targeting ADAR1 with a drug called Rexanib, scientists were able to shut down the gene and prevent mini tumors from cloning themselves in the bioreactor. This discovery has led them to believe that they may have found a "kill switch" for cancer, a way to stop the disease in its tracks before it has a chance to spread. But the story doesn't end there. The astronauts themselves are also part of the experiment, providing their blood so that researchers can study how their stem cells respond to spaceflight. A Whole New Field This study is part of a burgeoning field called Context-Accelerated Research and Development (CARD). Sure, it’s a mouthful. But it’s a simple idea. CARD is a way of using the special features of a specific environment to accelerate desired outcomes in research, design, or production. In space, for example, the microgravity environment allows for the production of materials with unique properties difficult (or impossible) to achieve on Earth. Case in point: The International Space Station has also been used to manufacture high-quality fiber optics, protein crystals, and other materials that benefit from the lack of gravity-induced convection and sedimentation. But it’s not just space… Also consider the extreme conditions found in the deep ocean -- high pressure, low temperature, and absence of sunlight. These conditions have led to the evolution of organisms with crazy biochemical properties. In light of this, there’s a growing interest in Deep Sea Bioprospecting: scientists search for useful substances -- like new medicines or enzymes -- and/or leverage these environments to accelerate research on new substances. Of course, CARD is something that we’ve been doing for a long time. But in the past we’ve been limited by the strength of our technological levers. Fortunately, AI can help. In fact, it’s already helping. [BREAKING: Supercomputing Firm Partners with NVIDIA]( On March 21, NVIDIA – the world’s leader in AI – is set to release their biggest AI innovation, known as the “X Chip,” and could easily send every single AI stock surging. But that doesn’t mean you should invest in any AI stock… Instead, there’s one tiny AI firm that has partnered with NVIDIA on this X Chip. And rumor has it that Nvidia is going to name this company in their March 21 press release… Which James Altucher believes will send this tiny stock on a 100X run, growing 10,000% by 2025. That’s why he advises you to invest in it today, before the March 21 release. [Get all the details right here.]( Don’t Miss Out One main limitation in CARD research has been our ability to process and analyze the vast amounts of data generated by experiments in extreme environments. In the past, scientists had to rely on manual analysis and interpretation -- time-consuming, prone to human error, and boring. BUT With the advent of AI and machine learning, we can now process and analyze data at an incredible pace. Already, scientists have used AI to analyze vast datasets from deep-sea expeditions, leading to the discovery of novel bioactive compounds with potential pharmaceutical applications. Another limitation: the cost and complexity of conducting experiments in extreme environments. Sending a research team to the bottom of the ocean or launching a spacecraft into orbit is no small feat. It requires significant resources, planning, and logistics. BUT Scientists have already deployed AI-powered robotics in extreme environments, such as the deep ocean, to autonomously collect samples and data, reducing the need for human intervention and lowering costs. Finally, the siloed nature of scientific research has long hindered progress and collaboration. Different fields of study have operated in isolation, with limited cross-pollination of ideas and insights. BUT AI is already helping to break down these silos by integrating knowledge from diverse domains and generating novel hypotheses. This is leading to a more interdisciplinary approach to CARD, where experts from different fields can collaborate and leverage each other's strengths to tackle complex problems. In all, this is great news. There’s lots of fear surrounding AI and what it means for our future. The danger in letting fear drive your decisions: You’ll wake up in five to ten years and see you missed out on the best time in history to build chest-thumping] wealth. Along that vein… In our recent Paradigm Mastermind Group event, James Altucher [describes why this might be your last chance before AI really takes off](. *** Fair Warning *** [This opportunity]( will be pulled from the internet at MIDNIGHT tonight More tomorrow. Until then, Chris Campbell For Altucher Confidential Rate this email Like Dislike Thanks for rating this content! Looks like something went wrong. Please try to rate again. Don’t Buy Any Crypto Until You Read This New Book! Do not… I repeat… [Do NOT buy a single cryptocurrency until you read this new book](. This could be the biggest opportunity of your life, but only if you act now. [Click here to see how to claim a copy of The Big Book of Crypto](. ☰ ⊗ [ARCHIVE]( [ABOUT]( [Contact Us]( © 2024 Paradigm Press, LLC. 1001 Cathedral Street, Baltimore, MD 21201. By submitting your email address, you consent to Paradigm Press, LLC. delivering daily email issues and advertisements. To end your Altucher Confidential e-mail subscription and associated external offers sent from Altucher Confidential, feel free to [click here.]( Please note: the mailbox associated with this email address is not monitored, so do not reply to this message. We welcome comments or suggestions at feedback@altucherconfidential.com. This address is for feedback only. For questions about your account or to speak with customer service, [contact us here]( or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Altucher Confidential is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our [Privacy Statement.]( If you are having trouble receiving your Altucher Confidential subscription, you can ensure its arrival in your mailbox by [whitelisting Altucher Confidential.](